Literature DB >> 2233610

[Long-term therapy of tumor pain using morphine-retard tablets].

J Sorge1, C Lehmkuhl, K Lohse, H Herrmann, I Pichlmayr.   

Abstract

We analysed the effect of sustained-release morphine tablets in 174 patients with severe cancer pain. A good relief of pain could be obtained in 65% of the patients within the first week and in 80% of the patients at the end of therapy. The mean daily dose was at 178 mg morphine, six patients needed more than 1000 mg per day. The sustained-release morphine was given at fixed intervals, in 80% of the cases every eight hours. No severe side-effects were associated with long-term morphine therapy. We often saw nausea and vomiting, constipation and drowsiness, but these side-effects decreased after the first weeks of treatment. Only in ten patients we had to stop therapy because of side-effects. Morphine can be used successfully in the treatment of cancer pain for long periods without concern about tolerance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2233610

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  3 in total

1.  [Prescription of strong opioids by physicians.].

Authors:  J Sorge; M Zenz
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

2.  Attitudes of Swiss physicians in prescribing opiates for cancer pain.

Authors:  F Stiefel; R Morant; A Radziwill; H J Senn
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

3.  [Opioids in "non-malignant" pain-results of long-term treatment in patients with rheumatic disease.].

Authors:  J Sorge; B Steffmann; C Lehmkuhl; I Pichlmayr
Journal:  Schmerz       Date:  1991-06       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.